Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic Index

Publisher： John Wiley & Sons Inc

E-ISSN： 1524-4741|21|2|127-132

ISSN： 1075-122x

Source： THE BREAST JOURNAL, Vol.21, Iss.2, 2015-03, pp. : 127-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ductal carcinoma in situ of the breast: 11 reasons to consider treatment with excision alone

By Silverstein Melvin J  

Women's Health, Vol. 4, Iss. 6, 2008-11 ,pp. : 565-577

Future Medicine

Access to resources Recommend Favorite

The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12‐gene DCIS score™ result

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 935-940

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ductal Carcinoma in situ of the Breast: Diagnosis and Management

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-01 ,pp. : 588-595

Karger

Access to resources Recommend Favorite

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy

By  

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (ELECTRONIC), Vol. 98, Iss. 5, 2017-10 ,pp. : 289-295

John Wiley & Sons Inc

Access to resources Recommend Favorite

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 476-480

John Wiley & Sons Inc

Access to resources Recommend Favorite